EUVIMEDEUVIMED entdecken
Scoping Review

A systematic scoping review of published economic analyses of public cord blood banking: Is it time to reassess?

Luke E Allan iD, Risa Shorr iD, Matthew Seftel, Pierre J A Villeneuve

Transfusion · 2026

DOI: 10.1111/trf.18483 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Transfusion, 2026. Verfasst von Luke E Allan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Dartmouth College, Hanover, New Hampshire, USA. Hauptthemen laut MEDLINE: Fetal Blood, Blood Banks, Cord Blood Stem Cell Transplantation. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Public banking of umbilical cord blood (UCB) remains important as a source of donor cells for hematopoietic cell transplantation (HCT). Given reductions in global cord blood transplant activity, the economic value of UCB banking may be questioned. We performed a scoping review to gain a full and current understanding of economic evaluations of public UCB banking.

Methods

We conducted a systematic search to June 2024 in Medline, Embase, Cochrane Central, Health Technology Assessment, Econlit, Scopus, and cumulative index to nursing and allied health literature (CINAHL) databases.

Results

Our search identified 13 studies published between 1999 and 2019, predominantly from the United States and Europe. Of these, five are classified as full economic evaluations, with two employing cost‐effectiveness analysis, one applying cost‐utility analysis and two applying cost–benefit analysis. Key findings reveal a shift from evaluating the optimal inventory size and costs associated with establishing cord banks, to the evaluation of strategies that increase usage and reduce costs of bank operations. Only two studies considered the societal gain from transplant survivors, noting many cord blood transplant recipients are pediatric with significant gain in quality‐adjusted life years that offset the high costs of operating public cord banks. Studies addressing the needs of underrepresented populations were lacking.

Conclusions

Our analysis highlights the evolving landscape of public UCB banking economic evaluations. Updated full economic studies are needed to understand the current landscape given potential usage by specific sub‐groups of the population, reduced global usage for HCT, and the emergence of novel uses of cord blood.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal BloodBlood BanksCord Blood Stem Cell TransplantationHumansCost-Benefit AnalysisHematopoietic Stem Cell Transplantation

Stichwörter der Autor:innen

allogeneicanalysiscosteconomichematopoietic cell transplantationpublic bankingumbilical cord bloodvalue

Autor:innen und Institutionen

  • Department of Economics, Dartmouth College, Hanover, New Hampshire, USA.
  • Ottawa Hospital Research Institute, Ottawa, Canada.
  • Information and Library Services, The Faculty of Medicine, University of Ottawa, Ottawa, Canada.
  • Stem Cells, Canadian Blood Services, Vancouver, Canada.
  • Faculty of Medicine, University of British Columbia, Vancouver, Canada.
  • Faculty of Medicine, University of Ottawa, Ottawa, Canada.

ORCID-Profile: Luke E Allan, Risa Shorr

Zitieren

APA

Allan, L. E., Shorr, R., Seftel, M., & Villeneuve, P. J. A. (2026). A systematic scoping review of published economic analyses of public cord blood banking: Is it time to reassess?. Transfusion. https://doi.org/10.1111/trf.18483

Vancouver

Allan LE, Shorr R, Seftel M, Villeneuve PJA. A systematic scoping review of published economic analyses of public cord blood banking: Is it time to reassess?. Transfusion. 2026. doi:10.1111/trf.18483

BibTeX
@article{Allan2026,
  author = {Allan, Luke E and Shorr, Risa and Seftel, Matthew and Villeneuve, Pierre J A},
  title = {A systematic scoping review of published economic analyses of public cord blood banking: Is it time to reassess?},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.18483}
}
Kostenlos starten →